Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Health

>> STROKE Latest News

APR 09, 2013 - MedPage Today

A Must Read - Share

New Drugs Better Value Than Warfarin (CME/CE)

(MedPage Today) -- The three newest anticoagulants -- dabigatran (Pradaxa), apixaban (Eliquis), and rivaroxaban (Xarelto) -- are cost-effective relative to warfarin for preventing stroke in patients with nonvalvular atrial fibrillation, researchers found.

Tags: New Drugs Better Value Than Warfarin (CME/CE),  Stroke Latest News